MYOVANT Trademark

Trademark Overview

On Wednesday, May 11, 2016, a trademark application was filed for MYOVANT with the United States Patent and Trademark Office. The USPTO has given the MYOVANT trademark a serial number of 87033599. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2024. This trademark is owned by Roivant Endocrinology Ltd.. The MYOVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause
myovant

General Information

Serial Number87033599
Word MarkMYOVANT
Filing DateWednesday, May 11, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2024
Registration Number5445805
Registration DateTuesday, April 17, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2018

Trademark Statements

Goods and ServicesPharmaceuticals for the use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUMITOMO PHARMA SWITZERLAND GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressBasel 4051
CH
Party NameMYOVANT SCIENCES GMBH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBasel 4051
CH
Party NameMYOVANT SCIENCES GMBH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBasel 4051
CH
Party NameMYOVANT SCIENCES GMBH
Party Type12 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressBASEL CH-4010
CH
Party NameMYOVANT SCIENCES LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressHAMILTON HM 11
BM
Party NameRoivant Endocrinology Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHamilton HM11
BM

Trademark Events

Event DateEvent Description
Friday, August 26, 2016ASSIGNED TO EXAMINER
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Saturday, May 14, 2016NEW APPLICATION ENTERED
Monday, May 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 17, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 2, 2016NON-FINAL ACTION E-MAILED
Friday, September 2, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 27, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 11, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2017FINAL REFUSAL WRITTEN
Monday, February 27, 2017FINAL REFUSAL E-MAILED
Wednesday, May 24, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, May 24, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 24, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 24, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, May 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 14, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 4, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 18, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 6, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 29, 2017ASSIGNED TO PETITION STAFF
Thursday, November 30, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, September 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 3, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 18, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 25, 2017TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, November 6, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 15, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Monday, December 18, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, January 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 17, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 13, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 15, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 1, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

myovant symptoms treatment thereof infertility namely uterine fibroids issues menopause endometriosis